1. Home
  2. SOS vs BIVI Comparison

SOS vs BIVI Comparison

Compare SOS & BIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SOS
  • BIVI
  • Stock Information
  • Founded
  • SOS 2004
  • BIVI 2013
  • Country
  • SOS China
  • BIVI United States
  • Employees
  • SOS N/A
  • BIVI N/A
  • Industry
  • SOS Finance: Consumer Services
  • BIVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • SOS Finance
  • BIVI Health Care
  • Exchange
  • SOS Nasdaq
  • BIVI Nasdaq
  • Market Cap
  • SOS 10.7M
  • BIVI 11.9M
  • IPO Year
  • SOS 2017
  • BIVI N/A
  • Fundamental
  • Price
  • SOS $1.84
  • BIVI $1.87
  • Analyst Decision
  • SOS
  • BIVI
  • Analyst Count
  • SOS 0
  • BIVI 0
  • Target Price
  • SOS N/A
  • BIVI N/A
  • AVG Volume (30 Days)
  • SOS 1.6M
  • BIVI 316.9K
  • Earning Date
  • SOS 09-24-2025
  • BIVI 11-12-2025
  • Dividend Yield
  • SOS N/A
  • BIVI N/A
  • EPS Growth
  • SOS N/A
  • BIVI N/A
  • EPS
  • SOS N/A
  • BIVI N/A
  • Revenue
  • SOS $231,424,000.00
  • BIVI N/A
  • Revenue This Year
  • SOS N/A
  • BIVI N/A
  • Revenue Next Year
  • SOS N/A
  • BIVI N/A
  • P/E Ratio
  • SOS N/A
  • BIVI N/A
  • Revenue Growth
  • SOS 150.42
  • BIVI N/A
  • 52 Week Low
  • SOS $1.18
  • BIVI $1.42
  • 52 Week High
  • SOS $2.04
  • BIVI $75.00
  • Technical
  • Relative Strength Index (RSI)
  • SOS 42.85
  • BIVI 33.55
  • Support Level
  • SOS $1.02
  • BIVI $1.54
  • Resistance Level
  • SOS $2.04
  • BIVI $1.68
  • Average True Range (ATR)
  • SOS 0.28
  • BIVI 0.14
  • MACD
  • SOS 0.20
  • BIVI 0.26
  • Stochastic Oscillator
  • SOS 79.90
  • BIVI 73.77

About SOS SOS Limited

SOS Ltd is a multifaceted company that leverages the power of data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other services. The company has three reporting segments: Commodity trading, Cryptocurrency mining, and Others. Key revenue is generated from Commodity trading.

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

Share on Social Networks: